Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Markers of bone status in diabetes mellitus patients treated with alendronate
2013-001222-26Phase 4Active
- Sponsor
- Aalborg University Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of alendronate in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), osteoporosis and 1 more, sponsored by Aalborg University Hospital. Primary endpoints: HbA1c and bone mineral density. Started Jul 2013; status: active.
02
Drugs
alendronate
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)osteoporosisosteopenia
Beyond the preview
Go deeper on 2013-001222-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001222-26.